Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Lab-on-a-Chip Homes in on How Cancer Cells Break Free

Published: Wednesday, April 01, 2009
Last Updated: Wednesday, April 01, 2009
Bookmark and Share
Johns Hopkins engineers have invented a method that could be used to help figure out how cancer cells break free from neighboring tissue, an "escape" that can spread the disease to other parts of the body.

The new lab-on-a-chip, described in the March issue of the journal Nature Methods, could lead to better cancer therapies.

Studying cell detachment at the subcellular level is critical to understanding the way cancer cells metastasize," says principal investigator Peter Searson, Reynolds Professor of Materials Science and Engineering. "Development of scientific methods to study cell detachment may guide us to prevent, limit or slow down the deadly spreading of cancer cells."

His team's research focuses on a missing puzzle piece in the common but unfortunate events that can occur in cancer patients. For example, cancer that starts in the breast sometimes spreads to the lungs.

That's because tumor cells detach and travel through the bloodstream to settle in other tissues. Scientists have learned much about how cancer cells attach to these surfaces, but they know little about how these insidious cells detach because no one had created a simple way to study the process.

Searson and two other scientists from Johns Hopkins' Whiting School of Engineering have solved this problem with a lab-on-a-chip device that can help researchers study cell detachment. With this device, they hope to discover exactly how cancer cells spread.


Johns Hopkins Cell Detachment Research with Lab-on-a-Chip
At left, the illustration shows adhesive complex formed between cell membrane-bound protein (integrin in gray) with peptide (RGD in red) tethered by thiol molecules (blue) to gold electrode (yellow) on glass slide (green). At right, electrochemical release of tethered peptide from the gold electrode results in local release of the RGD-integrin complex.
Diagram by Peter Searson

Then, the tethered molecules are released from one of the lines by a chemical reaction, specifically by "electrochemical reduction," Searson explains. Where these molecules are detached, that portion of the cell loses its grip on the surface of the chip. This segment of the cell pauses for a moment and then contracts forcefully toward its other end, which is still attached to the chip. The researchers were able to film this "tail snap" under a microscope.

"In the movies, you can see that the cell doesn't move immediately after the chemical reaction is triggered. We refer to this phenomenon as the induction time of the cell," Wildt says. "After this induction time, the cell then snaps back and contracts. We analyze the rate of the cell's contraction and then compare this information to separate cells released under different conditions using chemicals called inhibitors. From these results we are beginning to understand the processes that regulate cell detachment at the molecular level."

"It's very dramatic," says Denis Wirtz, a Johns Hopkins professor of chemical and biomolecular engineering and co-author of the Nature Methods paper. "The cell stretches way, way out across the chip and then, on command, the tail snaps toward the body of the cell."

Cells survive this programmed-release process and can be tested again and again, the researchers said.

Bridget Wildt, a materials science and engineering doctoral student in Searson's lab, used the device to perform and record movies of the live-cell experiments. Wildt tested cells from the connective tissue of mice during these experiments, but the team plans to try other types of cells in the future.

The researchers have speculated that the induction time for cancer cells, as compared to noncancerous cells, would be shorter because cancer cells are more pliable. In the near future, Wildt says, they plan to test this hypothesis in experiments with cancer cells. If this assumption proves correct, it may give them a tool to differentiate between cancerous and noncancerous cells.

Searson is director and Wirtz is associate director of the Johns Hopkins Institute for NanoBioTechnology. Their work was supported by grants from the U.S. National Institutes of Health, National Science Foundation and the Howard Hughes Medical Institute. Wildt's participation in the research was funded by the Achievement Rewards for College Scientists Foundation.

The new study — "Programmed subcellular release for studying the dynamics of cell detachment," Bridget Wildt, Denis Wirtz, and Peter C. Searson — can be viewed online at: www.nature.com/nmeth/journal/v6/n3/full/ nmeth.1299.html.


 



 


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tiny Lab Devices Could Attack Huge Problem of Drug-Resistant Infections
NIH-funded project aims for fast identification and destruction of deadly bacteria.
Monday, April 27, 2015
Triple-Negative Breast Cancer Immune Therapy
Experimental immune therapy tested in preliminary study of women with triple-negative breast cancer.
Tuesday, April 21, 2015
A New Tool for Understanding ALS: Patients’ Brain Cells
Researchers create a free public library of versatile stem cells from ALS patients.
Thursday, April 16, 2015
Tumor-Only Genetic Sequencing May Misguide Cancer Treatment in Nearly Half of All Patients
Johns Hopkins scientists say the genetic code of tumors must be compared to patients’ noncancer genome to get a true picture.
Thursday, April 16, 2015
New Cancer-Fighting Strategy Would Harden Cells to Prevent Metastasis
Potential drug for pancreatic cancer now being tested in animals.
Thursday, January 22, 2015
Training the Immune System to Destroy Cure-Defying Mutant HIV
This study reveals the reason behind the failure of luring HIV out of hiding, and charts a therapeutic strategy to eradicate mutant HIV-infected cells.
Thursday, January 08, 2015
New Genetic and Epigenetic Contributors to Diabetes Identified
Comparison of fat cells in mice and men hints at how genes and environment conspire to produce disease.
Wednesday, January 07, 2015
When DNA Gets Sent to Time-Out
New details revealed in the coordinated regulation of large stretches of DNA.
Tuesday, January 06, 2015
CRISPR Shows Promise in Engineering Human Stem Cells
Johns Hopkins study could advance use of stem cells for treatment and disease research.
Monday, January 05, 2015
Multiple Allergic Reactions Traced To Single Protein
Points to new strategy to reduce allergic responses to many medications.
Thursday, December 18, 2014
Brain Inflammation A Hallmark Of Autism
Johns Hopkins study is largest so far of gene expression in autism brains.
Thursday, December 11, 2014
Up-close Look at Cancer on the Move
Microscopic view of metastasis could give insight about how to keep cancer in check.
Friday, November 07, 2014
Newborns Exposed to Allergens May Have Lower Allergy and Asthma Risk
Newborns exposed to household germs, pet and rodent dander and roach allergens during their first year of life appear to have lower risk of developing asthma and allergies.
Tuesday, June 10, 2014
Experimental Vaccine Shows Promise against TB Meningitis
Study in animals lays groundwork for new prevention strategies in brain TB.
Tuesday, June 18, 2013
Seeing Through HIV's Disguises
Researchers identify 25 human proteins that may be crucial for HIV-1 infection and survival.
Friday, March 01, 2013
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!